Herbaspirillum: Difference between revisions

From IDWiki
Herbaspirillum
(Created page with "{{DISPLAYTITLE:''Herbaspirillum''}} == Background == * Genus of Stain::Gram-negative Shape::bacillus within the class Class::Betaproteobacteria * Oxidase-Oxidase::positive and afermentative * Environmental, associated with maize and rice * Generally non-pathogenic * Case reports of infections in humans, mostly in cystic fibrosis or immunocompromised patients<ref>Dhital R, Paudel A, Bohra N, Shin AK. ''Herbaspirillum'' Infection in Humans: A Case Report...")
 
No edit summary
 
Line 7: Line 7:
* Environmental, associated with maize and rice
* Environmental, associated with maize and rice
* Generally non-pathogenic
* Generally non-pathogenic
* Case reports of infections in humans, mostly in cystic fibrosis or immunocompromised patients<ref>Dhital R, Paudel A, Bohra N, Shin AK. ''Herbaspirillum'' Infection in Humans: A Case Report and Review of Literature. Case Rep Infect Dis. 2020 Feb 19;2020:9545243. doi: [https://doi.org/10.1155/2020/9545243 10.1155/2020/9545243]. PMID: 32148981; PMCID: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053444/ PMC7053444].</ref>
* Case reports of infections in humans, mostly in cystic fibrosis or immunocompromised patients[[CiteRef::dhital2020he]]


== Clinical Manifestations ==
== Clinical Manifestations ==

Latest revision as of 18:13, 19 September 2024


Background

  • Genus of Gram-negative bacillus within the class Betaproteobacteria
  • Oxidase-positive and afermentative
  • Environmental, associated with maize and rice
  • Generally non-pathogenic
  • Case reports of infections in humans, mostly in cystic fibrosis or immunocompromised patients1

Clinical Manifestations

  • Bacteremia without clinical focus
  • Central line infection
  • Pneumonia

Management

References

  1. ^  Rashmi Dhital, Anish Paudel, Nidrit Bohra, Ann K. Shin. Herbaspirillum Infection in Humans: A Case Report and Review of Literature. Case Reports in Infectious Diseases. 2020;2020:1-6. doi:10.1155/2020/9545243.